Cytosorbents
CTSO
#10823
Rank
A$22.65 M
Marketcap
A$7.19
Share price
-9.31%
Change (1 day)
612.26%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -A$27.41 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$37.21 Million. In 2025 the company made an earning of -A$12.7 Million, an increase over its 2024 earnings that were of -A$33.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$27.41 Million115.9%
2025 -A$12.7 Million-62.16%
2024 -A$33.55 Million-22.49%
2023 -A$43.29 Million-13.52%
2022 -A$50.06 Million34.04%
2021 -A$37.34 Million182.17%
2020 -A$13.24 Million-55.97%
2019 -A$30.06 Million14.17%
2018 -A$26.33 Million95.14%
2017 -A$13.49 Million-22.32%
2016 -A$17.37 Million39.1%
2015 -A$12.49 Million-12.89%
2014 -A$14.33 Million89%
2013 -A$7.59 Million26.65%
2012 -A$5.99 Million-26.02%
2011 -A$8.1 Million-288.45%
2010 A$4.29 M-4.17%
2009 A$4.48 M-287.19%
2008 -A$2.4 Million-47.12%
2007 -A$4.53 Million41.78%
2006 -A$3.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.21 B-19,085.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.14 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
A$81.93 M-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA